Market Overview

Jefferies Initiates Cellectis With Buy

Share:
Related
18 Stocks Moving In Friday's Pre-Market Session
18 Biggest Mid-Day Gainers For Wednesday

Analysts at Jefferies initiated coverage on Cellectis SA (ADR) (NASDAQ: CLLS) with a Buy rating.

The target price for Cellectis is set to $46.

Cellectis shares closed at $32.59 on Friday.

Latest Ratings for CLLS

DateFirmActionFromTo
Mar 2017NomuraInitiates Coverage OnBuy
Apr 2016Ladenburg ThalmannInitiates Coverage onBuy
Jul 2015Bank of AmericaInitiates Coverage onBuy

View More Analyst Ratings for CLLS
View the Latest Analyst Ratings

Posted-In: JefferiesInitiation Analyst Ratings

 

Related Articles (CLLS)

View Comments and Join the Discussion!